Artivion Announces Release Date and Teleconference Call Details for First Quarter 2023 Financial Results

Rhea-AI Summary

Artivion, Inc. (NYSE: AORT), a leader in cardiac and vascular surgery solutions, announced that it will release its first quarter 2023 financial results on May 4, 2023, post-market. A teleconference call and live webcast will follow at 4:30 p.m. ET, hosted by Chairman and CEO Pat Mackin. Investors can access the teleconference by dialing 862-298-0702. The replay will be available within an hour post-event. This announcement emphasizes Artivion's ongoing commitment to transparency with its stakeholders regarding its financial performance. The company's innovative product lines, including aortic stent grafts and surgical sealants, aim to address complex cardiac challenges, positioning Artivion within the competitive landscape of over 100 countries globally.

Positive

• Scheduled release of first quarter 2023 financial results indicates transparency.
• Teleconference and webcast provide direct communication with investors.

Negative

• None.

ATLANTA, April 20, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2023 financial results will be released on Thursday, May 4, 2023 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 862-298-0702 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13737780. 

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.

Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:
Artivion		Gilmartin Group LLC
D. Ashley Lee		Brian Johnston / Lynn Lewis
Executive Vice President &		Phone: 332-895-3222
Chief Financial Officer		investors@artivion.com
Phone: 770-419-3355

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-first-quarter-2023-financial-results-301803535.html

SOURCE Artivion, Inc.

FAQ

When will Artivion release its first quarter 2023 financial results?

Artivion will release its first quarter 2023 financial results on May 4, 2023, after the market closes.

What time is the Artivion teleconference for Q1 2023 results?

The teleconference will take place at 4:30 p.m. ET on May 4, 2023.

How can I access the Artivion Q1 2023 financial results webcast?

You can access the webcast through the Investors section of the Artivion website.